Here's Why Corvus (CRVS) is Poised for a Turnaround After Losing -25% in 4 Weeks

9d ago, source: Zacks.com on MSN

Corvus Pharmaceuticals (CRVS) has been on a downward spiral lately with significant selling pressure. After declining 25% over the past four weeks, the stock looks well positioned for a trend reversal ...

Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

16d ago, source: TMCnet

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced the initiation of the Company’s randomized, double-blind, placebo-controlled Phase 1 clinical ...

Community Health Systems gets grant for portable sleep diagnostic system for remote sleep apnea testing

9d ago, source: Pharmaceutical Technology

Revolutionize sleep diagnostics with Community Health Systems Inc's patented system, enabling remote testing for sleep apnea in multiple subjects. Real-time data collection and analysis for ...

Reviva Pharmaceuticals Holdings Inc. (RVPH) Stock: Analyzing the Market Value

7d ago, source: newsheater

The 36-month beta value for RVPH is at 0.04. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.” The public float ...